Literature DB >> 1597480

Selective translocation of the A chain of diphtheria toxin across the membrane of purified endosomes.

B Beaumelle1, L Bensammar, A Bienvenüe.   

Abstract

Translocation is a necessary and rate-limiting step for diphtheria toxin (DT) cytotoxicity. We have reconstituted DT translocation in a cell-free system using endosomes purified from lymphocytes and have demonstrated this using two different probe/cell systems, which provided identical results: 125I-DT/human CEM cells and 125I-transferrin-DT/mouse BW cells. The cell-free DT translocation process was found to be dependent on the presence of the pH gradient endosome (pH 5.3)/cytosol (pH 7). Among the pH equilibrating agents, nigericin (5 microM) was found to be the most effective, inhibiting DT translocation by 88%. An optimum pH value of 7 on the cytosolic side of the membrane (pH gradient approximately 1.7) was determined. ATP per se is not required for DT translocation. 125I-DT translocation was 3-fold more active from late than from early endosomes, probably because of their slightly more acidic pH. Only the A chain of the toxin was found to escape from either 125I-DT/CEM or 125I-transferrin-DT/BW endosomes. Translocation of control endosome labels (125I-transferrin and 125I-horseradish peroxidase) was never observed. We also show that DT receptors present on resistant (mouse) cells block the translocation of the toxin and are responsible for the resistance of these cells to DT.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597480

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  The membrane insertion of trichosanthin is membrane-surface-pH dependent.

Authors:  X F Xia; S F Sui
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

2.  Cationic cholesterol promotes gene transfection using the nuclear localization signal in protamine.

Authors:  Ari Noguchi; Naohide Hirashima; Mamoru Nakanishi
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

3.  HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses.

Authors:  Agnès Vendeville; Fabienne Rayne; Anne Bonhoure; Nadir Bettache; Philippe Montcourrier; Bruno Beaumelle
Journal:  Mol Biol Cell       Date:  2004-03-12       Impact factor: 4.138

4.  Selective membrane permeabilization by the rotavirus VP5* protein is abrogated by mutations in an internal hydrophobic domain.

Authors:  W Dowling; E Denisova; R LaMonica; E R Mackow
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  Toward intracellular targeted delivery of cancer therapeutics: progress and clinical outlook for brain tumor therapy.

Authors:  Hetal Pandya; Waldemar Debinski
Journal:  BioDrugs       Date:  2012-08-01       Impact factor: 5.807

6.  Calorimetric studies on the stability of the ribosome-inactivating protein abrin II: effects of pH and ligand binding.

Authors:  J Krupakar; C P Swaminathan; P K Das; A Surolia; S K Podder
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

Review 7.  A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.

Authors:  John E Weldon; Ira Pastan
Journal:  FEBS J       Date:  2011-06-02       Impact factor: 5.622

8.  Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains.

Authors:  P A Orlandi; P H Fishman
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

9.  Involvement of ATP-dependent Pseudomonas exotoxin translocation from a late recycling compartment in lymphocyte intoxication procedure.

Authors:  M Alami; M P Taupiac; H Reggio; A Bienvenüe; B Beaumelle
Journal:  Mol Biol Cell       Date:  1998-02       Impact factor: 3.612

Review 10.  Modification of membrane permeability by animal viruses.

Authors:  L Carrasco
Journal:  Adv Virus Res       Date:  1995       Impact factor: 9.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.